Variant report
Variant | esv2759437 |
---|---|
Chromosome Location | chr6:67664566-67688283 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:67680520..67684153-chr6:67686504..67689501,3 | MCF-7 | breast: | |
2 | chr6:67664280..67666953-chr6:67670600..67673248,2 | MCF-7 | breast: | |
3 | chr6:67680520..67684153-chr6:67686504..67689501,3 | MCF-7 | breast: | |
4 | chr4:106066864..106069364-chr6:67678829..67681478,2 | MCF-7 | breast: | |
5 | chr6:67664280..67666953-chr6:67670600..67673248,2 | MCF-7 | breast: | |
6 | chr6:67660837..67662514-chr6:67666593..67669025,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000168769 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs192759654 | chr6:67671002-67671003 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs548833896 | chr6:67671020-67671021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551127342 | chr6:67671026-67671027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs200744969 | chr6:67671058-67671059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs143199678 | chr6:67671061-67671062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs74278672 | chr6:67671062-67671063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571133008 | chr6:67671072-67671073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs397769412 | chr6:67671078-67671079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs112420637 | chr6:67671084-67671085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs77888393 | chr6:67671121-67671122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs558111100 | chr6:67671164-67671165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs377649247 | chr6:67671187-67671188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs183590545 | chr6:67671195-67671196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs370890371 | chr6:67671198-67671199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs567293062 | chr6:67671223-67671224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs114111493 | chr6:67671247-67671248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs79843459 | chr6:67671253-67671254 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs571858005 | chr6:67671351-67671352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs570327883 | chr6:67671404-67671405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs567135726 | chr6:67671415-67671416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs6933579 | chr6:67671416-67671417 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs559148201 | chr6:67671420-67671421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs6912895 | chr6:67671497-67671498 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs149548713 | chr6:67671501-67671502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs555043479 | chr6:67671569-67671570 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs146028133 | chr6:67671575-67671576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs570832402 | chr6:67671602-67671603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs543786512 | chr6:67671636-67671637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs537891729 | chr6:67671647-67671648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs139937782 | chr6:67671674-67671675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs188526522 | chr6:67671700-67671701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs192475382 | chr6:67671703-67671704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs564700859 | chr6:67671704-67671705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs527476095 | chr6:67671728-67671729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs547324354 | chr6:67671739-67671740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs114240474 | chr6:67671743-67671744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs529766687 | chr6:67671752-67671753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs372735463 | chr6:67671890-67671891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs549719802 | chr6:67671897-67671898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs143353159 | chr6:67671927-67671928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs573280565 | chr6:67671934-67671935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs577894628 | chr6:67671946-67671947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs542240302 | chr6:67671963-67671964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs566421938 | chr6:67671966-67671967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs5877063 | chr6:67671967-67671968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs555809336 | chr6:67671969-67671970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs535198991 | chr6:67672032-67672033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs201537915 | chr6:67672040-67672041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs554900907 | chr6:67672064-67672065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs574842196 | chr6:67672065-67672066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:67671000-67672000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
2 | chr6:67671000-67672000 | Enhancers | NHEK | skin |
3 | chr6:67671600-67672200 | Enhancers | HMEC | breast |
4 | chr6:67686200-67686400 | Enhancers | Fetal Lung | lung |
5 | chr6:67686600-67687600 | Weak transcription | Fetal Lung | lung |
6 | chr6:67687600-67688200 | Enhancers | Fetal Lung | lung |